Mandate

Vinge advises BHG Group in connection with the acquisition of Hafa Bathroom Group

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 94% of the shares in Hafa Bathroom Group.

Hafa Bathroom Group is Sweden’s largest privately-owned bathroom company with a market leading online platform. The company primarily sells products under the three trademarks of Hafa, NORO and Westerbergs and conducts operations in all of the Nordic countries and in the Baltic Region. During 2020, the turnover amounted to approximately MSEK 200 with good profitability.

BHG Group is the largest online actor within consumer trading in the Nordic Region and the largest actor in Europe within home improvement, which includes both Do It Yourself and Home Furnishing. BHG Group’s e-trading operations employ approximately 2,000 people and include more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

The transaction is subject to customary approvals by public authorities.

Vinge’s team consisted of Kristian Ford together with, among others, Niklas Törnell, Lena Westberg, Julia Ahlqvist, Karin Gynnerstedt, Johanne Örnfeldt Svensson, Philip Åberg and Pär Remnelid (competition law).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026